#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Juvenile idiopathic arthritis Congenital pseudarthrosis Oesophageal achalasia Friedreich's ataxia Arrhythmia Cataract Squamous cell carcinoma of the cervix Metastases to central nervous system Adenocarcinoma gastric Marginal zone lymphoma Acute promyelocytic leukaemia Arrhythmogenic right ventricular dysplasia Acute graft versus host disease Acute lymphocytic leukaemia Vascular calcification More trials…

    Learn about Rare Diseases

    Stevens-Johnson syndrome Sjogren’s syndrome – Treatment Waldenstrom’s macroglobulinaemia – Diagnostics Haemophilia B without inhibitors – Basic Information Hereditary hypophosphataemic rickets Familial haemophagocytic lymphohistiocytosis – Life with Disease Gastrointestinal stromal tumour – Basic Information Ehlers-Danlos syndrome – Diagnostics Mantle cell lymphoma – Treatment Progressive multifocal leukoencephalopathy – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    177LU-FAP-2286 Esketamine Loncastuximab Tesirine Bemnifosbuvir Hemisulfate NVG-2089 Phenylalanine Levoleucovorin Cusatuzumab Human Coagulation Factor Ix Riociguat Sapropterin Dihydrochloride Enfuvirtide Vixarelimab 4-Hydroxy-N-Desmethyltamoxifen Mps-216 Apremilast Apraglutide Olaparib TALADEGIB ANX007 More therapies…

    Learn about Your Condition

    Cervix carcinoma stage I Agitation postoperative Corneal graft rejection Endometrial adenocarcinoma Endotracheal intubation Cardiac failure congestive Palpitations Autoimmune uveitis Lung adenocarcinoma stage III Metabolic syndrome Inflammation Tumour of ampulla of Vater Erythema multiforme Hepatobiliary cancer Influenza More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Musculoskeletal Diseases

  • Study on DMD06-MAB Injection for Duchenne Muscular Dystrophy in Non-Ambulant Patients

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Dmd06-Mab
    Italy

  • Study of NMD670 tablets to improve muscle strength in adults with Type 3 spinal muscular atrophy who can walk

    Not recruiting

    2 1
    Investigated Diseases:
    • Spinal muscular atrophy
    Investigated Drugs:
    • Nmd670
    Belgium Denmark Germany Italy The Netherlands Spain

  • Study on Long-Term Safety and Effectiveness of Vamorolone in Boys with Duchenne Muscular Dystrophy Who Completed Previous Vamorolone Studies

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Duchenne muscular dystrophy
    Investigated Drugs:
    • Vamorolone
    Belgium Czechia Greece Ireland The Netherlands Spain

  • Study on Esflurbiprofen and Paracetamol for Pain Relief in Patients with Limb Bruises

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Contusion
    Investigated Drugs:
    • Esflurbiprofen
    • Paracetamol
    Germany

  • Study on Intrathecal Morphine for Pain Relief in Patients with Hip Fractures Undergoing Surgery

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Femoral neck fracture
    Czechia

  • Study on Denosumab for Healing Bone Fractures in Diabetic Patients with Charcot Foot

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Neuropathic arthropathy
    • Diabetes mellitus
    Investigated Drugs:
    • Saline
    • Denosumab
    The Netherlands
Previous Page
1 … 47 48 49 50 51 … 67
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!